These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 115098)

  • 41. Penicillinase-producing Neisseria gonorrhoeae in Canada.
    Dillon JR; Pauzé M; Jessamine AG
    Can Med Assoc J; 1981 Oct; 125(8):851-5. PubMed ID: 6796248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic resistance in gonorrhoea with special reference to rosoxacin in the treatment of a multi-resistant case.
    Mahendran R; Jayakuru GN
    Ceylon Med J; 1981 Jun; 26(2):94-8. PubMed ID: 6821032
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug-resistant gonorrhea infections in Canada. Plasma-mediated resistance.
    Bull Pan Am Health Organ; 1986; 20(1):72-4. PubMed ID: 3094611
    [No Abstract]   [Full Text] [Related]  

  • 44. Decrease in the incidence of tetracycline resistance in strains of Neisseria gonorrhoeae in the nineties.
    Bodonaik NC
    West Indian Med J; 2003 Sep; 52(3):228-30. PubMed ID: 14649105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

  • 46. Future treatment of gonorrhea--novel emerging drugs are essential and in progress?
    Unemo M; Shafer WM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):357-60. PubMed ID: 25907334
    [No Abstract]   [Full Text] [Related]  

  • 47. [Acute gonorrhea. Treatment schedules. Evaluation].
    Belli L; Casco RH; Melgar A; Mugico B; Famiglietti AM; Griemberg G
    Med Cutan Ibero Lat Am; 1989; 17(5):299-302. PubMed ID: 2516187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial resistance in Neisseria gonorrhoeae.
    Rice RJ
    Cleve Clin J Med; 1992; 59(1):97-8. PubMed ID: 1551223
    [No Abstract]   [Full Text] [Related]  

  • 49. Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
    Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM;
    Lancet Infect Dis; 2016 Sep; 16(9):1005-1006. PubMed ID: 27684341
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnosis and treatment of gonorrhea in the female.
    Lucas JB; Price EV; Thayer JD; Schroeter A
    N Engl J Med; 1967 Jun; 276(26):1454-9. PubMed ID: 4961108
    [No Abstract]   [Full Text] [Related]  

  • 51. Antimicrobial resistance in Neisseria gonorrhoeae and limited treatment options.
    Zafar A; Jabeen K
    J Pak Med Assoc; 2007 Jul; 57(7):333-4. PubMed ID: 17867252
    [No Abstract]   [Full Text] [Related]  

  • 52. Cephalosporin resistant Neisseria gonorrhoeae: time to consider gentamicin?
    Ross JD; Lewis DA
    Sex Transm Infect; 2012 Feb; 88(1):6-8. PubMed ID: 22250178
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibiotic sensitivity of Neisseria gonorrhoeae recorded in a Bombay hospital in 1979-80.
    Gohil AH; Kelkar SS
    Indian J Med Res; 1985 Oct; 82():304-10. PubMed ID: 3935579
    [No Abstract]   [Full Text] [Related]  

  • 54. Decreased in vitro antibiotic susceptibility of Neisseria gonorrhoeae isolates in Hong Kong.
    Egglestone SI; Kam KM; Lai CF
    Genitourin Med; 1990 Dec; 66(6):462-3. PubMed ID: 2125026
    [No Abstract]   [Full Text] [Related]  

  • 55. Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    Alirol E; Wi TE; Bala M; Bazzo ML; Chen XS; Deal C; Dillon JR; Kularatne R; Heim J; Hooft van Huijsduijnen R; Hook EW; Lahra MM; Lewis DA; Ndowa F; Shafer WM; Tayler L; Workowski K; Unemo M; Balasegaram M
    PLoS Med; 2017 Jul; 14(7):e1002366. PubMed ID: 28746372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi.
    Ison CA; Dillon JA; Tapsall JW
    Lancet; 1998; 351 Suppl 3():8-11. PubMed ID: 9652713
    [No Abstract]   [Full Text] [Related]  

  • 57. Antimicrobial susceptibility of Neisseria gonorrhoeae, the essential drug list, and HIV/AIDS control.
    Adu-Sarkodie Y
    Trop Doct; 1995 Jan; 25(1):45. PubMed ID: 7886837
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination therapy and the resistant gonococcus.
    Barlow D; Thin RN; Phillips I
    Lancet; 1983 Jan; 1(8316):125-6. PubMed ID: 6129438
    [No Abstract]   [Full Text] [Related]  

  • 59. Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan.
    Deguchi T; Yasuda M; Maeda S
    Ann Intern Med; 2008 Sep; 149(5):363-4. PubMed ID: 18765714
    [No Abstract]   [Full Text] [Related]  

  • 60. Research for new antibiotics in the treatment of gonorrhea and nonspecific urethritis.
    Diena BB; Eidus L
    Can Med Assoc J; 1978 Nov; 119(9):1009-10. PubMed ID: 105799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.